Wegener's granulomatosis: Experience from a Brazilian tertiary center

Clinical Rheumatology

Volumn 29, Issue 8, 2010, Pages 855-860

  De Souza, Fernando Henrique Carlos ^a   Halpern, Ari Stiel Radu ^a   Barbas, Carmen Silvia Valente ^a   Shinjo, Samuel Katsuyuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical features; Epidemiological studies; Southern hemisphere; Systemic vasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; FEMALE; HEART INFARCTION; HERPES ZOSTER; HUMAN; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; WEGENER GRANULOMATOSIS; BLOOD; BRAZIL; FOLLOW UP; GRANULOMATOSIS WITH POLYANGIITIS; IMMUNOLOGY; JOINT; KIDNEY; MIDDLE AGED; NERVOUS SYSTEM; PATHOPHYSIOLOGY; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BRAZIL; CHILD; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JOINTS; KIDNEY; MALE; MIDDLE AGED; NERVOUS SYSTEM; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; YOUNG ADULT; GRANULOMATOSIS WITH POLYANGIITIS;

EID: 77956265081     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1408-4     Document Type: Article

References (35)

1. Hoffman GS, Kerr GS, Leavitt RY et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488-498
2. Koldingsnes W, Nossent H (2000) Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 43:2481-2487
3. Watts RA, Scott DG (1997) Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 11:191-217
4. Watts R, Gonzales-Gay M, Garcia-Porrua C et al (2000) ANCA-associated vasculitis in two European regions. Clin Exp Immunol 120 (Suppl 1):60
5. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J (2003) The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 49:388-393
6. Reinhold-Keller E, Zeidler A, Mock C et al (1996) Epidemiology of primary systemic vasculitis in North and South Germany [abstract]. Sarcoidosis 13 (Suppl 3):272
7. Bligny D, Mahr A, Toumelin PL et al (2004) Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum 51:83-91
8. Anderson G, Coles ET, Crane M et al (1992) Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83:427-438
9. Reinhold-Keller E, Beuge N, Latza U et al (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43:1021-1032
10. Jennings CR, Jones NS, Dugar J et al (1998) Wegener's granulomatosis-a review of diagnosis and treatment in 53 subjects. Rhinology 36:188-191
11. Fauci AS, Woff SM (1994) Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine [Baltimore] 73:315-324
12. Matteson EL, Gold KN, Bloch DA (1996) Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am J Med 101:129-134
13. Westman KW, Bygren PG, Olsson H et al (1998) Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9:842-852
14. Gibson A, Stamp LK, Chapman PT, O'Donnell JL (2006) The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology 45:624-628
15. Cisternas ML, Soto L, Jacobelli S et al (2005) Características clínicas de granulomatosis de Wegener y poliangeítis microscópica em pacientes chilenos. Rev Med Chil 133:273-278
16. Gamron S, Eugenia Muscellini M, Onetti L et al (2006) Wegener's granulomatosis: its prevalence in a ten-year period in the rheumatology service of the Clinic Hospital, Cordoba, Argentina. Rev Fac Cien Med Univ Nasc Cordoba 63:53-56
17. Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107
18. The WGET Research Group (2002) Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 23:450-468
19. Exley AR, Bacon PA, Luqmani RA et al (1998) Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 37:57-63
20. Seo P, Min YI, Holbrook JT et al (2005) Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 52:2168-2178
21. Bajema IM, Hagen EC, van der Woude FJ et al (1997) Wegener's granulomatosis: a meta-analysis of 349 literary case reports. J Lab Clin Med 129:17-22
22. Faurschou M, Mellemkjaer L, Sorensen IJ, Thomsen BS, Dreyer L, Baslund B (2009) Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis Rheum 60:1187-1189
23. Merkel PA, Lo GH, Holbrook JT et al (2005) Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) study. Ann Intern Med 142:620-626
24. Allenbach Y, Seror R, Pagnox C et al (2009) High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 68:564-567
25. Aasarod K, Inversen BM, Hammerstrom J et al (2000) Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 15:611-618
26. Krafcik SS, Covin RB, Lynch JP et al (2006) Wegener's granulomatosis in the elderly. Chest 109:430-437
27. Le Thi Huong DU, Wechsler B, Cabane J et al (1988) Wegener's granulomatosis: clinical aspects, nosologic problems: review of the literature a propos of 30 cases. Ann Med Interne 139:169-182
28. Vassallo M, Shepherd RJ, Iqbal P et al (1997) Age-related variations in presentation and outcome in Wegener's granulomatosis. J R Coll Physicians 31:396-400
29. Fauchais AL, Michon-Pasturel M, Rugale C et al (2001) Wegener's granulomatosis in the elderly patient [in French]. Rev Med Interne 22:127-131
30. Romas E, Murphy BF, d'Apice AJ et al (1993) Wegener's granulomatosis: clinical features and prognosis in 37 patients. Aust NZ J Med 23:168-175
31. Zycinska K, Wardyn KA, Tyszko P et al (2007) Analysis of early death based on the prediction model in Wegener's granulomatosis with pulmonary and renal involvement. J Physiol Pharmacol 58 (Suppl 5):829-837
32. Jarrousse B, Guillevin L, Bindi P et al (1993) Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 11:615-621
33. Godeau B, Coutant-Perronne V, Du Huong LT et al (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246-251
34. Godeau B, Mainardi JL, Roudot-Thoraval F et al (1995) Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis 54:991-994
35. Gatenby PA, Lucas RM, Engelsen O et al (2009) Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417-1424